Liangzhi Wang Selected Research

Liangzhi Wang Research Topics

3	Fibrosis (Cirrhosis) 09/2023 - 10/2015
2	Diabetic Nephropathies (Diabetic Nephropathy) 06/2023 - 01/2022
2	Diabetic Angiopathies (Diabetic Angiopathy) 05/2022 - 01/2022
2	Neoplasms (Cancer) 01/2022 - 01/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2015 - 01/2014
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 09/2023
1	Stomach Neoplasms (Stomach Cancer) 08/2023
1	Hip Fractures (Intertrochanteric Fractures) 04/2022
1	Osteoporosis 04/2022
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Bone Resorption 05/2019

2	Proteins (Proteins, Gene)FDA Link 05/2022 - 10/2015
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2022
2	Carbon Tetrachloride (Tetrachloromethane)IBA 10/2015 - 01/2014
2	Eosine Yellowish-(YS) (Eosin)IBA 10/2015 - 01/2014
2	Hydroxyproline (4 Hydroxyproline)IBA 10/2015 - 01/2014
1	ProteomeIBA 09/2023
1	Semaphorin-3AIBA 08/2023
1	Neuropilin-1IBA 08/2023
1	Messenger RNA (mRNA)IBA 06/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 05/2022
1	PolymersIBA 04/2022
1	Circular RNAIBA 01/2022
1	RamucirumabIBA 01/2021
1	Sirtuin 1IBA 05/2019
1	NAD (NADH)IBA 05/2019
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 10/2015
1	Hematoxylin (Haematoxylon)IBA 10/2015
1	geranylgeranylacetone (teprenone)IBA 10/2015
1	Chloroquine (Aralen)FDA LinkGeneric 01/2014

1	Therapeutics 08/2023